malignant tissue samples; adjacent normal tissue samples
-
not specified
Microarray; RT-qPCR; RNase R Treatment; Sanger Sequencing; Clinical Sample Validation; ROC Analysis; Cohort Study
Discriminates malignant vs adjacent normal prostate tissue (AUC 0.645).
circSTIL is down-regulated in prostate cancer tissue by RT-qPCR and provides moderate diagnostic discrimination between tumor and adjacent normal tissue. It was not retained as an independent circRNA predictor for BCR in multivariable modeling.
0.6663
Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological Factors.
combined biological and clinical study